Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Gunilla Olsson |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting / Margareta Reis en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 4 (Agosto)
[artículo]
Título : Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting Tipo de documento: texto impreso Autores: Margareta Reis, Autor ; Gunilla Olsson, Autor ; Björn Carlsson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 406-413 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Citalopram, Anticonceptivos orales, Trastorno depresivo mayor, Inhibidores selectivos de la recaptación de serotonina, Aspectos sexuales, Fumar. Resumen: The prescribing of selective serotonin reuptake inhibitors for adolescents is extensive despite the fact that there are few pharmacokinetic (PK), efficacy, safety, or tolerability studies on this group. This study reports the PK findings from two trials in adolescents treated with citalopram (CIT) in naturalistic clinical settings: one retrospective and one prospective. Link: ./index.php?lvl=notice_display&id=31058
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 406-413[artículo] Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting [texto impreso] / Margareta Reis, Autor ; Gunilla Olsson, Autor ; Björn Carlsson, Autor . - 2023 . - pp. 406-413.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 406-413
Palabras clave: Citalopram, Anticonceptivos orales, Trastorno depresivo mayor, Inhibidores selectivos de la recaptación de serotonina, Aspectos sexuales, Fumar. Resumen: The prescribing of selective serotonin reuptake inhibitors for adolescents is extensive despite the fact that there are few pharmacokinetic (PK), efficacy, safety, or tolerability studies on this group. This study reports the PK findings from two trials in adolescents treated with citalopram (CIT) in naturalistic clinical settings: one retrospective and one prospective. Link: ./index.php?lvl=notice_display&id=31058